Evidence map›Paper›PMID 37968356›Full record

ArticleScientific reports2023

Retraction Note: The toxicity and therapeutic effects of single-and multi-wall carbon nanotubes on mice breast cancer.

Arghavan Kavosi, Saeideh Hosseini Ghale Noei, Samaneh Madani, Solmaz Khalighfard, Saeed Khodayari, Hamid Khodayari, Malihe Mirzaei, Mohammad Reza Kalhori, Majid Yavarian, Ali Mohammad Alizadeh and 1 more

Abstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Arghavan KavosiDepartment of Cellular and Molecular Biology, Faculty of Advanced Sciences and Technology, Islamic Azad University, Pharmaceutical Science Branch, Tehran, Iran.
Saeideh Hosseini Ghale NoeiDepartment of Cellular and Molecular Biology, Faculty of Advanced Sciences and Technology, Islamic Azad University, Pharmaceutical Science Branch, Tehran, Iran.
Samaneh MadaniDepartment of Cellular and Molecular Biology, Faculty of Advanced Sciences and Technology, Islamic Azad University, Pharmaceutical Science Branch, Tehran, Iran.
Solmaz KhalighfardDepartment of Biology, Islamic Azad University, Science and Research Branch, Tehran, Iran.
Saeed KhodayariCancer Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Hamid KhodayariCancer Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Malihe MirzaeiDepartment of Biology, Islamic Azad University, Arsanjan Branch, Arsanjan, Iran.
Mohammad Reza KalhoriCancer Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Majid YavarianHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Ali Mohammad AlizadehCancer Research Center, Tehran University of Medical Sciences, Tehran, Iran. aalizadeh@sina.tums.ac.ir.ORCID http://orcid.org/0000-0002-1147-3335
Mojtaba FalahatiDepartment of Nanotechnology, Faculty of Advance Science and Technology, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran. falahati@ibb.ut.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37968356
PMCPMC10651863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.